Literature DB >> 8339011

Treatment of low responders.

S J Muasher1.   

Abstract

Mesh：

Year:  1993        PMID： 8339011     DOI： 10.1007/bf01207730

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN： 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  13 in total

1.  Combined impact of the number of pre-ovulatory oocytes and cryopreservation on IVF outcome.

Authors:  J P Toner; R G Brzyski; S Oehninger; L L Veeck; S Simonetti; S J Muasher
Journal:  Hum Reprod       Date:  1991-02       Impact factor: 6.918

2.  Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age.

Authors:  J P Toner; C B Philput; G S Jones; S J Muasher
Journal:  Fertil Steril       Date:  1991-04       Impact factor: 7.329

3.  High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients.

Authors:  V C Karande; G S Jones; L L Veeck; S J Muasher
Journal:  Fertil Steril       Date:  1990-03       Impact factor: 7.329

4.  Significance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization.

Authors:  E Khalifa; J P Toner; S J Muasher; A A Acosta
Journal:  Fertil Steril       Date:  1992-04       Impact factor: 7.329

5.  Use of gonadotrophin-releasing hormone agonists in controlled ovarian hyperstimulation for in vitro fertilization.

Authors:  S J Muasher
Journal:  Clin Ther       Date:  1992       Impact factor: 3.393

6.  High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization.

Authors:  G E Hofmann; J P Toner; S J Muasher; G S Jones
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-10

7.  Cumulative conception and livebirth rates after in-vitro fertilisation.

Authors:  S L Tan; P Royston; S Campbell; H S Jacobs; J Betts; B Mason; R G Edwards
Journal:  Lancet       Date:  1992-06-06       Impact factor: 79.321

8.  Timing of oocyte retrieval in cycles with a spontaneous luteinizing hormone surge in a large in vitro fertilization program.

Authors:  K Droesch; S J Muasher; D Kreiner; G S Jones; A A Acosta; Z Rosenwaks
Journal:  Fertil Steril       Date:  1988-09       Impact factor: 7.329

9.  A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization.

Authors:  G A San Roman; E S Surrey; H L Judd; J F Kerin
Journal:  Fertil Steril       Date:  1992-10       Impact factor: 7.329

10.  Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment.

Authors:  R G Brzyski; S J Muasher; K Droesch; S Simonetti; G S Jones; Z Rosenwaks
Journal:  Fertil Steril       Date:  1988-12       Impact factor: 7.329
View more
  9 in total

1.  High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome.

Authors:  G Barroso; S Oehninger; A Monzó; P Kolm; W E Gibbons; S J Muasher
Journal:  J Assist Reprod Genet       Date:  2001-09       Impact factor: 3.412

2.  Cumulative exposure to high estradiol levels during the follicular phase of IVF cycles negatively affects implantation.

Authors:  Murat Arslan; Silvina Bocca; Ebru Ozturk Arslan; Hakan E Duran; Laurel Stadtmauer; Sergio Oehninger
Journal:  J Assist Reprod Genet       Date:  2007-02-16       Impact factor: 3.412

3.  A randomized prospective cross-over study of highly purified follicle-stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in women aged 37-41 years.

Authors:  S Bassil; C Wyns; J Donnez
Journal:  J Assist Reprod Genet       Date:  2000-02       Impact factor: 3.412

4.  Preferred protocol: controlled ovarian stimulation.

Authors:  H W Jones
Journal:  J Assist Reprod Genet       Date:  1993-10       Impact factor: 3.412

Review 5.  Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet.

Authors:  S J Fasouliotis; A Simon; N Laufer
Journal:  J Assist Reprod Genet       Date:  2000-08       Impact factor: 3.412

Review 6.  Contemporary pharmacological manipulation in assisted reproduction.

Authors:  Judith A F Huirne; Cornelis B Lambalk; Andre C D van Loenen; Roel Schats; Peter G A Hompes; Bart C J M Fauser; Nick S Macklon
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF.

Authors:  Sozos J Fasouliotis; Neri Laufer; Shelley Sabbagh-Ehrlich; Aby Lewin; Arye Hurwitz; Alex Simon
Journal:  J Assist Reprod Genet       Date:  2003-11       Impact factor: 3.412

8.  Treatment-associated serum FSH levels in very poor responders to ovarian stimulation.

Authors:  Peyman Saadat; Cristin C Slater; John K Jain; David E Tourgeman; Frank Z Stanczyk; Richard J Paulson
Journal:  J Assist Reprod Genet       Date:  2003-10       Impact factor: 3.412

9.  Poor responders in in vitro fertilization (IVF) therapy: the challenge continues.

Authors:  S Oehninger
Journal:  Facts Views Vis Obgyn       Date:  2011
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.